stem cell therpay market global revenue, trends, growth, share, size and forecast to 2022

1

Stem Cell Therapy Market By

Treatments (Allogeneic Stem Cell

Therapy, Autologous Stem Cell

Therapy), Applications (Oncology, Eye

Diseases, Central Nervous System

Diseases, Musculoskeletal Diseases,

Wound & Injuries, Metabolic Disorders,

Cardiovascular Disorders, Immune

System Disorders), End-users

(Hospitals, Ambulatory Surgical

Centers) and Geography – Global

Opportunity Analysis and Industry

Forecast, 2014-2022

SCALAR MARKET RESEARCH INC.

OCTOBER 2016

2

Table of Contents

1 Introduction .................................................................................................................................. 11

2 Market Overview .......................................................................................................................... 12

2.1 Definitions ............................................................................................................................. 12

2.2 Research Methodology ......................................................................................................... 13

2.3 Market Segmentation ........................................................................................................... 15

2.4 Assumptions .......................................................................................................................... 16

3 Executive Summary ....................................................................................................................... 17

4 Market Dynamics .......................................................................................................................... 23

4.1 Drivers ................................................................................................................................... 24

4.2 Restraints .............................................................................................................................. 26

4.3 Opportunities ........................................................................................................................ 27

4.4 Trends ................................................................................................................................... 27

5 Industry Analysis ........................................................................................................................... 28

5.1 Industry Overview ................................................................................................................. 28

5.2 Regulatory Analysis ............................................................................................................... 30

5.2.1 Europe ........................................................................................................................... 30

5.2.2 U.S. FDA ......................................................................................................................... 30

5.3 Pipeline Analysis .................................................................................................................... 31

5.4 Pricing Analysis ...................................................................................................................... 34

6 Stem Cell Therapy Market, by Treatments ................................................................................... 35

6.1 Market Overview .................................................................................................................. 35

6.2 Market Share Segmentation ................................................................................................. 36

6.3 Revenue Segmentation ......................................................................................................... 38

6.4 Treatments ............................................................................................................................ 39

6.4.1 Allogeneic Stem Cell Therapy........................................................................................ 39

6.4.2 Autologous Stem Cell Therapy ...................................................................................... 41

7 Stem Cell Therapy Market, by Applications .................................................................................. 43

7.1 Market Overview .................................................................................................................. 43


SAMPLE

3


7.4 Applications ........................................................................................................................... 48

7.4.1 Oncology ....................................................................................................................... 48

7.4.2 Eye Diseases .................................................................................................................. 50

7.4.3 Central Nervous System Diseases ................................................................................. 51

7.4.4 Musculoskeletal Diseases ............................................................................................. 52

7.4.5 Wound & Injuries .......................................................................................................... 53

7.4.6 Metabolic Disorders ...................................................................................................... 54

7.4.7 Cardiovascular Disorders .............................................................................................. 55

7.4.8 Immune System Disorders ............................................................................................ 56

8 Stem Cell Therapy Market, by End-Users ..................................................................................... 58

8.1 Market Overview .................................................................................................................. 58


8.3 Revenue Share Segmentation ............................................................................................... 61

8.4 End-Users .............................................................................................................................. 62

8.4.1 Hospitals ........................................................................................................................ 62

8.4.2 Ambulatory Surgical Centers ........................................................................................ 63

9 Stem Cell Therapy Market, By Regions ......................................................................................... 64



9.3 North America ....................................................................................................................... 68

9.3.1 By Regions ..................................................................................................................... 69

9.3.1.1 U.S. ............................................................................................................................ 69

9.3.1.2 Canada ...................................................................................................................... 69

9.3.2 By Treatments ............................................................................................................... 70

9.3.3 By Applications .............................................................................................................. 71

9.3.4 By End-Users ................................................................................................................. 72

9.4 Europe ................................................................................................................................... 73

9.4.1 By Regions ..................................................................................................................... 74

9.4.1.1 Germany .................................................................................................................... 74

9.4.1.2 U.K ............................................................................................................................. 74

SAMPLE

4

9.4.1.3 France ........................................................................................................................ 74

9.4.1.4 Spain .......................................................................................................................... 74

9.4.1.5 Rest of Europe ........................................................................................................... 75

9.4.2 By Treatments ............................................................................................................... 76

9.4.3 By Applications .............................................................................................................. 77

9.4.4 By End-Users ................................................................................................................. 78

9.5 Asia-Pacific ............................................................................................................................ 79

9.5.1 By Regions ..................................................................................................................... 80

9.5.1.1 China ......................................................................................................................... 80

9.5.1.2 India........................................................................................................................... 80

9.5.1.3 Japan ......................................................................................................................... 80

9.5.1.4 South Korea ............................................................................................................... 80

9.5.2 By Treatments ............................................................................................................... 82

9.5.3 By Applications .............................................................................................................. 83

9.5.4 By End-Users ................................................................................................................. 84

9.6 Rest of the World (ROW) ...................................................................................................... 85

9.6.1 By Regions ..................................................................................................................... 86

9.6.1.1 Latin America ............................................................................................................ 86

9.6.1.2 Middle East & Africa.................................................................................................. 86

9.6.2 By Treatments ............................................................................................................... 87

9.6.3 By Applications .............................................................................................................. 88

9.6.4 By End-Users ................................................................................................................. 89

10 Competitive Landscape ................................................................................................................. 90

10.1 Key Innovator Companies ..................................................................................................... 90

11 Key Market Players ....................................................................................................................... 92

11.1 Vericel Corporation ............................................................................................................... 92

11.1.1 Overview ....................................................................................................................... 92

11.1.2 Key Strategies ................................................................................................................ 92

11.1.3 Recent Developments ................................................................................................... 92

11.2 Stem Cells, Inc. ...................................................................................................................... 93

11.2.1 Overview ....................................................................................................................... 93

SAMPLE

5

11.2.2 Key Strategies ................................................................................................................ 93


11.3 Mesoblast Ltd. ....................................................................................................................... 94

11.3.1 Overview ....................................................................................................................... 94

11.3.2 Key Strategies ................................................................................................................ 94


11.4 Gamida Cell ........................................................................................................................... 95

11.4.1 Overview ....................................................................................................................... 95

11.4.2 Key Strategies ................................................................................................................ 95


11.5 Osiris Therapeutics, Inc. ........................................................................................................ 96

11.5.1 Overview ....................................................................................................................... 96

11.5.2 Key Strategies ................................................................................................................ 96


11.6 Chiesi Farmaceutici S.p.A. ..................................................................................................... 97

11.6.1 Overview ....................................................................................................................... 97

11.6.2 Key Strategies ................................................................................................................ 97


11.7 ReNeuron Group, plc ............................................................................................................ 98

11.7.1 Overview ....................................................................................................................... 98

11.7.2 Key Strategies ................................................................................................................ 98


12 Scalar 360 Degree Market Perspective ......................................................................................... 99

13 Appendix ..................................................................................................................................... 100

SAMPLE

6

List of Tables

Table 1. Research Methodology ..................................................................................................... 13

Table 2. Assumptions ...................................................................................................................... 16

Table 3. Global Stem Cell Therapy Market Size (US$ billion), (2016-2022) .................................... 18

Table 4. Global Stem Cell Therapy Market Summary ..................................................................... 22

Table 5. Stem Cell Therapy Market in emerging countries ............................................................ 27

Table 6. Stem Cell Therapeutic Products Available in the Market ................................................. 28

Table 7. Stem Cell Therapies in Phase 3 & Pre-registration Stage of the Development (2015) ..... 33

Table 8. Companies with Number of Stem Cell Therapies in Pipeline (2015) ................................ 34

Table 9. Average Treatment Costs .................................................................................................. 34

Table 10. Global Stem Cell Therapy Market Size (US$ billion), By Treatments (2014-2022) ........... 38

Table 11. Global Allogeneic Stem Cell Therapy Market Size (US$ billion), By Regions (2014-2022) 39

Table 12. Global Autologous Stem Cell Therapy Market Size (US$ billion),By Regions (2014-2022)

41

Table 13. Global Stem Cell Therapy Market Size (US$ billion), By Applications (2014-2022) .......... 47

Table 14. Focused Areas in Oncology for Stem Cell Therapies ......................................................... 48

Table 15. Global Stem Cell Therapy Market for Oncology; Market Size (US$ billion) (2014-2022) . 49

Table 16. Global Stem Cell Therapy Market for Eye Diseases; Market Size (US$ billion) (2014-2022)

50

Table 17. Global Stem Cell Therapy Market for Central Nervous System Diseases; Market Size (US$

billion) (2014-2022) ............................................................................................................................... 51

Table 18. Global Stem Cell Therapy Market for Musculoskeletal Diseases; Market Size (US$ billion)

(2014-2022) 52

Table 19. Global Stem Cell Therapy Market for Wound & Injuries; Market Size (US$ billion) (2014-

2022) 53

Table 20. Global Stem Cell Therapy Market for Metabolic Disorders; Market Size (US$ billion)

(2014-2022) 54

Table 21. Global Stem Cell Therapy Market for Cardiovascular Disorders; Market Size (US$ billion)

(2014-2022) 55

Table 22. Focused Areas in Immune System Disorders for Stem Cell Therapies ............................. 56

Table 23. Global Stem Cell Therapy Market for Immune System Disorders; Market Size (US$

billion) (2014-2022) ............................................................................................................................... 57

Table 24. Global Stem Cell Therapy Market Size (US$ billion), By End-users (2014-2022) .............. 61

SAMPLE

7

Table 25. Global Stem Cell Therapy Market for Hospitals; Market Size (US$ billion) (2014-2022) . 62

Table 26. Global Stem Cell Therapy Market for Ambulatory Surgical Centers; Market Size (US$

billion) (2014-2022) ............................................................................................................................... 63

Table 27. Global Stem Cell Therapy Market Size (US$ billion), By Regions (2014-2022) ................. 67

Table 28. Stem Cell Therapy Market in North America; Market Size (US$ billion) (2014-2022) ...... 68

Table 29. Stem Cell Therapy Market in U.S; Market Size (US$ billion), (2014-2022) ....................... 69

Table 30. Stem Cell Therapy Market in Canada; Market Size (US$ billion), (2014-2022) ................ 69

Table 31. Stem Cell Therapy Market in North America; Market Size (US$ billion), By Treatment

(2014-2022) ..........................................................................................................................................70

Table 32. Stem Cell Therapy Market in North America; Market Size (US$ billion), By Applications

(2014-2022) ..........................................................................................................................................71

Table 33. Stem Cell Therapy Market in North America; Market Size (US$ billion), By End-users

(2014-2022). .......................................................................................................................................... 72

Table 34. Stem Cell Therapy Market in Europe; Market Size (US$ billion)....................................... 73

Table 35. Stem Cell Therapy Market in Germany; Market Size (US$ billion),(2014-2022) .............. 74

Table 36. Stem Cell Therapy Market in U.K; Market Size (US$ billion), (2014-2022) ....................... 74

Table 37. Stem Cell Therapy Market in France; Market Size (US$ billion),(2014-2022) .................. 74

Table 38. Stem Cell Therapy Market in Spain; Market Size (US$ billion), (2014-2022) .................... 74

Table 39. Stem Cell Therapy Market in Rest of Europe; Market Size (US$ billion), (2014-2022) ..... 75

Table 40. Stem Cell Therapy Market in Europe; Market Size (US$ billion), By Treatment (2014-

2022).................. ................................................................................................................................... 76

Table 41. Stem Cell Therapy Market in Europe; Market Size (US$ billion), By Applications (2014-

2022)........... .......................................................................................................................................... 77

Table 42. Stem Cell Therapy Market in Europe; Market Size (US$ billion), By End-users (2014-

2022)............ ......................................................................................................................................... 78

Table 43. Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion) ................................ 79

Table 44. Stem Cell Therapy Market in China; Market Size (US$ billion), (2014-2022) ................... 80

Table 45. Stem Cell Therapy Market in India; Market Size (US$ billion), (2014-2022) .................... 80

Table 46. Stem Cell Therapy Market in Japan; Market Size (US$ billion), (2014-2022) ................... 80

Table 47. Stem Cell Therapy Market in South Korea; Market Size (US$ billion), (2014-2022) ......... 80

Table 48. Stem Cell Therapy Market in Rest of Asia-Pacific; Market Size (US$ billion), (2014-2022)

81

Table 49. Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By Treatment (2014-

2022) 82

SAMPLE

8

Table 50. Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By Applications

(2014-2022) 83

Table 51. Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By End-users (2014-

2022) 84

Table 52. Stem Cell Therapy Market in Rest of the World (ROW); Market Size (US$ billion) .......... 85

Table 53. Stem Cell Therapy Market in Latin America; Market Size (US$ billion), (2014-2022) ...... 86

Table 54. Stem Cell Therapy Market in Middle East & Africa; Market Size (US$ billion), (2014-2022)

86

Table 55. Stem Cell Therapy Market in Rest of the World (ROW); Market Size (US$ billion), By

Treatment (2014-2022) ......................................................................................................................... 87

Table 56. Stem Cell Therapy Market in Rest of the World (ROW); Market Size (US$ billion), By

Applications (2014-2022) ...................................................................................................................... 88

Table 57. Stem Cell Therapy Market in Rest of the World; Market Size (US$ billion), By End-users

(2014-2022) ..........................................................................................................................................89

Table 58. Key Innovator Companies ................................................................................................. 90

Table 59. Acronyms ........................................................................................................................ 100

SAMPLE

9

List of Figures

Figure 1. Research Methodology ..................................................................................................... 14

Figure 2. Global Stem Cell Therapy Market Share(%), By Regions (2016 & 2022) .......................... 19

Figure 3. Global Stem Cell Therapy Market Share(%), By Treatments (2016 & 2022) .................... 19

Figure 4. Global Stem Cell Therapy Market Share(%), By Applications (2017 & 2022) ................... 20

Figure 5. Global Stem Cell Therapy Market Share(%), By End-users (2016 & 2022) ....................... 21

Figure 6. Stem Cell Therapy by Stage of Development (2015) ........................................................ 31

Figure 1. Stem Cell Therapy by Therapeutic Area (2015) ................................................................ 32

Figure 2. Global Stem Cell Therapy Market Size (US$ billion), By Treatments (2015) .................... 35

Figure 3. Global Stem Cells Therapy Market Share (%), By Treatments (2016 & 2022) ................. 36

Figure 4. Global Stem Cells Therapy Market Size (US$ billion), By Treatments (2014-2022) ......... 38

Figure 5. Global Allogeneic Stem Cell Therapy Market Size (US$ billion), By Regions (2016 & 2022)

39

Figure 6. Global Autologous Stem Cell Therapy Market Size (US$ billion), By Regions (2015 & 2022

41

Figure 7. Market Attractiveness for Major Stem Cell Therapy Applications (2017) ........................ 44

Figure 8. Forecasted Global Stem Cell Therapy Market Share (%), By Applications (2017 & 2022) 45

Figure 9. Global Stem Cell Therapy Market Size (US$ billion), By Applications (2017 & 2022) ....... 47

Figure 10. Global Stem Cells Therapy Market for Oncology; Market Size (US$ billion) (2017 &

2022) 49

Figure 11. Global Stem Cells Therapy Market for Eye Diseases; Market Size (US$ billion) (2017 &

2022) 50

Figure 12. Global Stem Cells Therapy Market for Central Nervous System Diseases; Market Size

(US$ billion) (2017 & 2022) ................................................................................................................... 51

Figure 13. Global Stem Cells Therapy Market for Musculoskeletal Diseases; Market Size (US$

billion) (2017 & 2022) ........................................................................................................................... 52

Figure 14. Global Stem Cells Therapy Market for Wound & Injuries; Market Size (US$ billion)

(2017 & 2022) 53

Figure 15. Global Stem Cells Therapy Market for Eye Metabolic Disorders; Market Size (US$

billion) (2017 & 2022) ........................................................................................................................... 54

Figure 16. Global Stem Cells Therapy Market for Cardiovascular Disorders; Market Size (US$

billion) (2017 & 2022) ........................................................................................................................... 55

SAMPLE

10

Figure 17. Global Stem Cells Therapy Market for Immune System Disorders; Market Size (US$

billion) (2017 & 2022) ........................................................................................................................... 56

Figure 18. Global Stem Cell Therapy Market Size (US$ billion), By End-users (2015) ................... 58

Figure 19. Global Stem Cell Therapy Market Share(%), By End-Users (2016 & 2022) .................. 59

Figure 20. Global Stem Cells Therapy Market Size (US$ billion), By End-users (2014-2022) ....... 61

Figure 21. Global Stem Cells Therapy Market for Hospitals; Market Size (US$ billion) (2016 &

2022) 62

Figure 22. Global Stem Cells Therapy Market for Ambulatory Surgical Centers; Market Size (US$

billion) (2016 & 2022) ........................................................................................................................... 63

Figure 23. Global Stem Cell Therapy Market Share (%), By Major Regions(2015 & 2022) ............ 65

Figure 24. Top 5 Countries, By Market Share (%) (2016) ............................................................... 66

Figure 25. Stem Cell Therapy Market in North America; Market Size (US$ billion)(2014-2022) ... 68

Figure 26. Stem Cell Therapy Market in North America; Market Size (US$ billion), By Treatment

(2014-2022) 70

Figure 27. Stem Cell Therapy Market in North America; Market Size (US$ billion), By End-users

(2014- 2022) 72

Figure 28. Stem Cell Therapy Market in Europe; Market Size (US$ billion)(2014-2022) ............... 73

Figure 29. Stem Cell Therapy Market in Europe; Market Size (US$ billion), By Treatment (2014-

2022) 76

Figure 30. Stem Cell Therapy Market in Europe; Market Size (US$ billion), By End-users (2014-

2022) 78

Figure 31. Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion)(2014-2022) ........ 79

Figure 32. Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By Treatment

(2014-2022) 82

Figure 33. Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By End-users

(2014-2022) 84

Figure 34. Stem Cell Therapy Market in Rest of the World; Market Size (US$ billion) (2014-2022)

85

Figure 35. Stem Cell Therapy Market in Rest of the World; Market Size (US$ billion), By

Treatment (2014-2022) ......................................................................................................................... 87

Figure 36. Stem Cell Therapy Market in Rest of the World (ROW); Market Size (US$ billion), By

End-users (2014-2022) .......................................................................................................................... 89

SAMPLE

12

2 Market Overview

2.1 Definitions

Global stem cell therapy market is defined as the market size and market share

estimation of the various segments of the stem cell therapy market, capturing

ongoing drivers, trends, challenges of the market, industry analysis involving the

regulatory analysis, and studying about the major participants and players in stem

cell therapy market environment.

The 'Global Stem Cell Therapy Market – Market Size and Forecast (2014–2022)'

report includes market size and forecast estimates for the period 2014 to 2022. The

scope of this report is commercially available regenerative stem cell therapy

products, pipeline analysis, and application of stem cell therapies in different

diseases. The report segments the market by treatments, applications, end-users,

and regions. The report has 2014 as the historic year, 2015 as base year and years

2016 to 2022 as forecast years.

This report defines stem cell therapy as–

Stem cell therapy is defined as the introduction of the stem cells into the damaged or

diseased tissue. These stem cells posses the ability to renew themselves and give

rise to other cells, which in turn replaces the damaged organs and tissues in the

body. Stem cell therapy comes under the umbrella of the global regenerative

medicines.

Allogeneic Stem cell therapy treatment type as–

Allogeneic transplant is stem cell transplant treatment in which the stem cell are

received by the donor which can be a relative, a family member, or a third person.

Autologous Stem cell therapy treatment type as–

Allogeneic transplant is stem cell transplant treatment in which the stem cell are

received by the patient from his own blood.

SAMPLE

13

2.2 Research Methodology

The market study of stem cell therapy market incorporates prolonged two-way

approaches, secondary and primary research to collect the information commercially

and study the market. The data collection part was focused, and related to capturing

the whole market from various perspective. Data collected from multiple sources was

logically linked and analyzed by our analysts.

Secondary Data

Secondary data gathering procedure, with subsequent references such as company

websites, journals, magazines, directories, databases such as Bloomberg, Hoovers,

Factiva, company annual reports, press releases, white papers, and government

publishing sources also have been taken into consideration. Data from these

sources has been used to obtain industry analysis, company profiles, and other key

areas such as market drivers, opportunities, and trends from stem cell therapy

market perspective.

Table 1. Research Methodology

Report Parameter Secondary Source

Market Size, Share, Revenue Company Annual Reports, SEC Filings, Financials,

Press Releases, Directories, Journals.

Industry Analysis Company websites, Market journals, White

papers, Magazines, other Market studies.

Competitive Landscape Company Annual Reports, Financials, Press

Releases, Investors Relations, Directories,

Journals.

Primary Data

Primary data is the most important data in the research study. Primary data has

been considered and linked to the report to make the study more crisp and

informative. Structured interviews with industry specialists, VPs, CEO’s, directors,

technology consultants were taken to collect the key primary data. The primary data

was focused on both, the demand and supply side of the market. Market Engineering

SAMPLE

14

was carried out from the data, and excessive analysis has been done on it. Primary

data was also considered extensively in validating the secondary content. Market

engineering process involved both top-down and bottom-up approach to estimate the

market size and market forecast and segment the market into more sub-segments.

Market size estimation

Both, top-down and bottom-up approaches were used to estimate the size of the

global stem cell therapy market.

Figure 1. Research Methodology

Global

Market

Size

Market-specific Revenues of Key Market

Players

Revenues of Key Market Players

Global Market

Size

Segment-specific Market Size

Regional

Market

Size

Bottom-up

Top-down

SAMPLE

15

2.3 Market Segmentation

Stem Cell Therapy Market

Treatments Applications End-users Regions

•Allogeneic Stem Cell Therapy

• AutologousStem Cell Therapy

• Oncology•Central Nervous System Diseases•Eye Diseases•Musculoskeletal Diseases•Wound & Injuries•Metabolic Disorders•Cardiovascular Disorders•Immune System Disorders

• Hospitals

• Ambulatory Surgical Centers

• North America

• Europe

• Asia-Pacific

• Rest of the World

SAMPLE

17

3 Executive Summary

Stem cell therapy is defined as the introduction of the stem cells into the damaged or

diseased tissue. These stem cells posses the ability to renew themselves and give

rise to other cells, which in turn replaces the damaged organs and tissues in the

body. Stem cell therapy comes under the umbrella of the global regenerative

medicines.

The stem cell therapy market offers many growth opportunities and driving factors as

compared to the restraining factors. It is stated by various research scientists that

development of stem cell population and their preservation will be essential for

commercialization of stem cell therapies. Thus, large numbers of key companies

such as Baxter International., Teva Pharmaceutical, and others are in constant

efforts to develop stem cell therapies. For which, these companies are rigorously

increasing their research and development expenses on clinical trials to introduce

stem cell therapies which would ultimately drive the market growth. Furthermore,

demand for stem cell therapies is also expected to increase due to the rise in the

incidence of life-threatening diseases such as cancer, cardiovascular disorders, and

others. For these diseases, stem cell therapies have proven a promising option for

the disease diagnosis and mitigation. However, a strict regulatory framework for the

stem cell therapies to develop these products restricts companies to invest in this

market, leading to hampering the market growth during the future period.

The major revenue opportunities are expected to come from application sectors such

as Oncology, Cardiovascular disorders, and immune system disorders. Whereas

cardiovascular disorders will account for 50.4% of the total revenue generated by

2022, oncology and immune system disorders will demand a great potential towards

stem cell therapy market. Allogeneic based stem cell therapy will dominate in the

stem cell therapy market while autologous based stem cell therapy will see the

decrease during the forecast as large number of stem cell therapies for

cardiovascular diseases are already in phase 3 and pre-registration stages. Areas

for investment in the stem cell therapy market will focus on improving research and

SAMPLE

19

Figure 2. Global Stem Cell Therapy Market Share(%), By Regions (2016 & 2022)

59.1%25.5%

12.0%

3.5%

57.1%

26.1%

13.2%

3.6%

North America

Europe

Asia-Pacif ic

Rest of the World

Source: Scalar Market Research Analysis

Figure 3. Global Stem Cell Therapy Market Share(%), By Treatments (2016 & 2022)

48.3%51.7%

37.7%

62.3%

Autologous

Allogeneic


Inside circle shows the market share for the year 2016 & outside circle shows market share

for the year 2022.

SAMPLE

22

Table 4. Global Stem Cell Therapy Market Summary

Global Stem Cell Therapy Market Market Size (US$ billion) CAGR%

(2016-2022) 2016 2022

Total 11.99 60.94 31.1

Trea

tmen

t Autologous Stem Cell Therapy

Allogeneic Stem Cell Therapy

Ap

plic

atio

ns

Oncology

Eye Diseases

Central Nervous System Diseases

Musculoskeletal Diseases

Wound & Injuries

Metabolic Disorders

Cardiovascular Disorders

Immune System Disorders

End

-use

rs Hospitals

Ambulatory Surgical Centers

Reg

ion

s

North America

Europe

Asia-Pacific

Rest of the World


Note: '*’ represents CAGR (2017-2022) as stem cell therapies for these diseases are

still in experimental stages and are expected to enter the market in 2017-2018.

SAMPLE

23

4 Market Dynamics

SAMPLE

24

4.1 Drivers

Drivers Impact on the Market

2014-2016 2017-2019 2020-2022

Increase in aging population and

chronic diseases, and their need

of alternative medicines

●=High ◑=Medium ◔=Low

1. Increase in aging population and chronic diseases, and their need of

alternative medicines

SAMPLE

28

5 Industry Analysis

5.1 Industry Overview

The stem cell industry is still considered as an under-regulated industry. Large

numbers of companies are marketing unproven treatments which can be very

harmful to the patients. There are mostly 15 stem cell therapeutic products available

on the market and has been regulated. All other stem cell procedures are still in

experimental stages.

Hemacord; manufactured by New York Blood Center (NYBC); the cord blood product

was approved by FDA in 2011, is excluded from the list along with four more cord

blood products approved since 2011.

The following table gives the list of stem cell therapeutic products that are

commercially available in the market and regulated. All the following products are

authorized for sales and available in the market and are approved by or regulated by

the federal agency.

Table 6. Stem Cell Therapeutic Products Available in the Market

No. Product Company Country Year of Release

Indication Regulation

1

2

3

4

5

6

7

8

9

10

SAMPLE

29

11

12

13

14

15


SAMPLE

35

6 Stem Cell Therapy Market, by Treatments

6.1 Market Overview

Figure 2. Global Stem Cell Therapy Market Size (US$ billion), By Treatments

(2015)

USD9.60

Billion

On the basis of treatments, the global stem cell therapy market is segmented into

allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell

treatment is expected to be the largest treatment segment of this market in 2016.

This segment was valued at US XX billion and is expected to be valued at US XX

billion in 2016. It is expected to have a XX% share of the total stem cell therapy

market in 2016. It is also expected to be the fastest-growing market segment. This

segment will grow at a CAGR of XX% between 2016 and 2022, to reach USXX

billion by 2022.

Allogeneic Stem Cell Therapy| US XX Billion

Autologous Stem Cell Therapy |US XX Billion

SAMPLE

38

6.3 Revenue Segmentation

Figure 4. Global Stem Cells Therapy Market Size (US$ billion), By Treatments

(2014-2022)

4.0

4

4.8

3

5.7

8

7.2

3

9.0

6 11

.38

14

.34 18

.12 22

.96

3.6

7

4.7

7

6.2

0

8.3

8 11

.33 15

.31 2

0.7

1

28

.03

37

.98

2014 2015 2016 2017 2018 2019 2020 2021 2022

Autologous Allogeneic


Table 10. Global Stem Cell Therapy Market Size (US$ billion), By Treatments

(2014-2022)

Treatment 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR% (2016-2022)

Autologous

Allogeneic

TOTAL 31.1%


Allogeneic stem cell therapy treatment accounts for the largest treatment of the stem

cell therapy market in 2015. This market segment is expected to grow at a CAGR of

XX% from USXX billion in 2015 to US XX billion in 2022.

SAMPLE

43

7 Stem Cell Therapy Market, by Applications

7.1 Market Overview

The applications segment of the Stem Cell Therapy market included in this report are

Oncology diseases, Eye Diseases, Central Nervous System Diseases,

Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular

Diseases, and Immune system disorders. Musculoskeletal diseases, wound &

injuries, and eye diseases were the largest application segments in 2015, but is

expected to lose its market share to cardiovascular diseases and oncology diseases

during the forecast period.

This report gives the market size of stem cell therapy for eye diseases,

musculoskeletal diseases, and wound & injuries application segments for years 2014

to 2016, considering these applications as widely accepted as safe and effectively

proven by the medical community. All other application segments are still in

experimental stages and yet to be proven; thus their market sizes are forecasted

from 2017 to 2022 accordingly.

SAMPLE

44

Figure 7. Market Attractiveness for Major Stem Cell Therapy Applications (2017)

Applications Market Size Growth Rate Overall Attractiveness

Wound & Injuries

Musculoskeletal

Diseases

Eye Diseases

Cardiovascular

Disorders

Immune System

Disorders

Metabolic disorders

Central Nervous System

Diseases

Oncology

●=Significantly Attractive ◑=Attractive ◔=Less Attractive

SAMPLE

47

7.3 Revenue Segmentation

Figure 9. Global Stem Cell Therapy Market Size (US$ billion), By Applications

(2017 & 2022)

0.25

2.11

0.31

4.52

6.19

0.47

1.28

0.47

3.17

2.64

2.57

6.92

9.15

2.74

30.72

3.02

Oncology

Eye Diseases



Wound & Injuries

Metabololic Disorders



2022

2017


Table 13. Global Stem Cell Therapy Market Size (US$ billion), By Applications

(2014-2022)

Applications 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR% (2017-2022)

Oncology

Eye Diseases



Wound & Injuries

Metabolic Disorders



Total 31.3%


SAMPLE

58

8 Stem Cell Therapy Market, by End-Users

8.1 Market Overview

Figure 18. Global Stem Cell Therapy Market Size (US$ billion), By End-users (2015)

USD9.60

Billion

On the basis of end-users, the global stem cell therapy market is segmented into

hospitals and ambulatory surgical centers. Hospitals are expected to be the largest

end-user segment of this market in 2016. This segment is expected to be valued at

US XX billion in 2016. It is expected to have a XX% share of the total stem cell

therapy market in 2016. It is also expected to be the fastest-growing market

segment. This segment will grow at a CAGR of XX% between 2016 and 2022, to

reach US$ XX billion by 2022. However, the prevalence of ambulatory surgical

centers is more in regulated markets as compared to non-regulated markets.

Hospitals| US XX Billion

Ambulatory Surgical Centers |US XX Billion

SAMPLE

61

8.3 Revenue Share Segmentation

Figure 20. Global Stem Cells Therapy Market Size (US$ billion), By End-users

(2014-2022)

4.8

7

6.1

0

7.6

5

10

.00

13

.12

17

.25 22

.75 3

0.0

8

39

.89

2.8

3

3.5

0

4.3

4

5.6

1

7.2

7

9.4

5 12

.31

16

.07 21

.05

2014 2015 2016 2017 2018 2019 2020 2021 2022

Hospitals Ambulatory Surgical Centres


Table 24. Global Stem Cell Therapy Market Size (US$ billion), By End-users (2014-

2022)

End-Users 2014 2015 2016 2017 2018 2019 2020 2021 2022 CAGR%

(2016-

2022)

Hospitals

Ambulatory

Surgical Centers

TOTAL 31.1%


SAMPLE

64

9 Stem Cell Therapy Market, By Regions

The regional segments of the Stem Cell Therapy market included in this report are

North America (NA), Europe (EU), Asia-Pacific (APAC), and the Rest of the World

(ROW). North America was the largest regional segment in 2015, while North

America, and Asia Pacific is expected to be the fastest-growing regional segment in

the forecast period.

SAMPLE

65

9.1 Market Share Segmentation

Figure 23. Global Stem Cell Therapy Market Share (%), By Major Regions (2015 &

2022)

59.1%25.5%

12.0%

3.5%

57.1%

26.1%

13.2%

3.6%

North America

Europe

Asia-Pacif ic

Rest of the World


Inside circle shows the market share for the year 2016 & outside circle shows market share

for the year 2022. SAMPLE

90

10 Competitive Landscape

10.1 Key Innovator Companies

The stem cell therapy industry is highly fragmented, and there are many companies

in the world who are targeting stem cell therapeutic products. In Europe, itself there

are more than 100 companies developing stem cell therapies and there are more

than 400 clinics for stem cell therapy in U.S. alone. The following table gives the list

of key innovators in stem cell therapeutics products across the geography.

Table 58. Key Innovator Companies

Geography/Country Company

United States

Asia-Pacific

Europe

SAMPLE

91

Israel


SAMPLE

100

13 Appendix

Table 59. Acronyms

CAGR Compounded Annual Growth Rate

NA North America

EU Europe

APAC Asia-Pacific

ROW Rest of the World

LA Latin America

NR Not Reported

R&D Research & Development

EMA European Medicines Agency

CNS Central Nervous System

SC Stem Cell

SAMPLE

stem cell therpay market global revenue, trends, growth, share, size and forecast to 2022

Business